|
caveolin-1 |
8 |
|
multiple sclerosis |
7 |
|
stroke |
7 |
|
nitration |
6 |
|
peroxynitrite |
6 |
|
t follicular helper |
6 |
|
ros |
5 |
|
ace2 |
4 |
|
acteoside |
4 |
|
activity-based sensing |
4 |
|
alisol b 23-acetate |
4 |
|
anti-coronavirus |
4 |
|
anti-immunoinflammatory activity |
4 |
|
autoimmune disorders |
4 |
|
batf |
4 |
|
brain microvascular endothelial cells |
4 |
|
breg cells |
4 |
|
calycosin |
4 |
|
chemiluminescence |
4 |
|
covid-19 |
4 |
|
cp: immunology |
4 |
|
depression |
4 |
|
experimental sjögren’s syndrome |
4 |
|
fenofibrate |
4 |
|
ferroptosis |
4 |
|
glycyrrhetinic acid |
4 |
|
hypochlorous acid |
4 |
|
icos |
4 |
|
il-10 |
4 |
|
in vivo imaging |
4 |
|
inflammation |
4 |
|
metabolism |
4 |
|
methotrexate |
4 |
|
migration |
4 |
|
mitophagy |
4 |
|
nadph oxidasei |
4 |
|
neural progenitor cells |
4 |
|
neurogenesis |
4 |
|
ppar |
4 |
|
rns |
4 |
|
sjogren's syndrome |
4 |
|
sjögren disease |
4 |
|
sjögren syndrome |
4 |
|
sjögren’s disease |
4 |
|
sjögren’s syndrome |
4 |
|
t follicular helper cells |
4 |
|
t follicular regulatory cells |
4 |
|
tlr |
4 |
|
autoimmunity |
3 |
|
chinese medicine |
3 |
|
drp1 |
3 |
|
dynamin-related protein 1 |
3 |
|
effector t cell |
3 |
|
experimental autoimmune encephalomyelitis |
3 |
|
high-mobility group box 1 |
3 |
|
il-2r |
3 |
|
ischemic stroke |
3 |
|
microenvironment |
3 |
|
microglia |
3 |
|
myeloperoxidase |
3 |
|
network pharmacology |
3 |
|
neuronal damages |
3 |
|
rehmapicroside |
3 |
|
adult hippocampal neurogenesis |
2 |
|
autophagy |
2 |
|
bdnf pathway |
2 |
|
bdnf/trkb/erk/creb pathway |
2 |
|
creb |
2 |
|
hippocampal neurogenesis |
2 |
|
naringin |
2 |
|
neural stem cells |
2 |
|
niuhuang qingxin wan |
2 |
|
reactive nitrogen species |
2 |
|
reactive oxygen species |
2 |
|
therapeutic compounds |
2 |
|
aerobic oxidation |
1 |
|
alpha chain e |
1 |
|
ampk |
1 |
|
ampk signaling |
1 |
|
ampk/sirt3-pgc1α axis |
1 |
|
antioxidant |
1 |
|
antiplatelets |
1 |
|
antithrombotic |
1 |
|
apoptosis antigen 1 |
1 |
|
apoptosis antigen 1 ligand |
1 |
|
bioactive components |
1 |
|
c-c chemokine receptor type 5 |
1 |
|
cardiovascular diseases |
1 |
|
dectin-1 |
1 |
|
diabetes |
1 |
|
early colorectal cancer |
1 |
|
energy metabolism pathway |
1 |
|
exercise |
1 |
|
galectin-3 |
1 |
|
ganoderma lucidum polysaccharides |
1 |
|
glucose catabolism |
1 |
|
glucose metabolism |
1 |
|
glutaredoxins |
1 |
|
glutathionylation |
1 |
|
glycolysis |
1 |
|
hepatic ros inhibition |
1 |
|
high salt |
1 |
|
human leukocyte antigen class i histocompatibility antigen |
1 |
|
human leukocyte antigen-a |
1 |
|
immune escape |
1 |
|
insulin resistance |
1 |
|
liver targeted nano-mitopbn |
1 |
|
mitochondria |
1 |
|
mitochondrial biogenesis |
1 |
|
mitochondrial function |
1 |
|
mn-sod |
1 |
|
mouse |
1 |
|
myocardial infarction |
1 |
|
nanoparticle |
1 |
|
oroxylin a |
1 |
|
oxidants |
1 |
|
oxidative stress |
1 |
|
p53 |
1 |
|
pancreatic mitochondria |
1 |
|
pentose pathway |
1 |
|
platelet aggregation and thrombosis |
1 |
|
platelet hyperreactivity |
1 |
|
prevention of diabetes |
1 |
|
radix rehmanniae |
1 |
|
reactive oxidative stress |
1 |
|
redox balance |
1 |
|
redox state |
1 |
|
shp-2 |
1 |
|
sirt3 |
1 |
|
td139 |
1 |
|
tumor hypoxia |
1 |
|
type 2 diabetes |
1 |
|
type 2 diabetes mellitus |
1 |
|
warburg effect |
1 |
